Jon T Willie1,2, James G Malcolm1, Matthew A Stern3, Lindsay O Lowder4, Stewart G Neill4, Brian T Cabaniss2, Daniel L Drane2,5,6, Robert E Gross1,2. 1. Department of Neurological Surgery, Emory University School of Medicine, Atlanta, Georgia. 2. Department of Neurology, Emory University School of Medicine, Atlanta, Georgia. 3. Medical Scientist Training Program, Emory University School of Medicine, Atlanta, Georgia. 4. Department of Pathology, Emory University School of Medicine, Atlanta, Georgia. 5. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. 6. Department of Neurology, University of Washington School of Medicine, Seattle, Washington.
Abstract
OBJECTIVE: Magnetic resonance (MR) thermography-guided laser interstitial thermal therapy, or stereotactic laser ablation (SLA), is a minimally invasive alternative to open surgery for focal epilepsy caused by cerebral cavernous malformations (CCMs). We examined the safety and effectiveness of SLA of epileptogenic CCMs. METHODS: We retrospectively analyzed 19 consecutive patients who presented with focal seizures associated with a CCM. Each patient underwent SLA of the CCM and adjacent cortex followed by standard clinical and imaging follow-up. RESULTS: All but one patient had chronic medically refractory epilepsy (median duration 8 years, range 0.5-52 years). Lesions were located in the temporal (13), frontal (five), and parietal (one) lobes. CCMs induced magnetic susceptibility artifacts during thermometry, but perilesional cortex was easily visualized. Fourteen of 17 patients (82%) with >12 months of follow-up achieved Engel class I outcomes, of which 10 (59%) were Engel class IA. Two patients who were not seizure-free from SLA alone became so following intracranial electrode-guided open resection. Delayed postsurgical imaging validated CCM involution (median 83% volume reduction) and ablation of surrounding cortex. Histopathologic examination of one previously ablated CCM following open surgery confirmed obliteration. SLA caused no detectable hemorrhages. Two symptomatic neurologic deficits (visual and motor) were predictable, and neither was permanently disabling. SIGNIFICANCE: In a consecutive retrospective series, MR thermography-guided SLA was an effective alternative to open surgery for epileptogenic CCM. The approach was free of hemorrhagic complications, and clinically significant neurologic deficits were predictable. SLA presents no barrier to subsequent open surgery when needed. Wiley Periodicals, Inc.
OBJECTIVE: Magnetic resonance (MR) thermography-guided laser interstitial thermal therapy, or stereotactic laser ablation (SLA), is a minimally invasive alternative to open surgery for focal epilepsy caused by cerebral cavernous malformations (CCMs). We examined the safety and effectiveness of SLA of epileptogenic CCMs. METHODS: We retrospectively analyzed 19 consecutive patients who presented with focal seizures associated with a CCM. Each patient underwent SLA of the CCM and adjacent cortex followed by standard clinical and imaging follow-up. RESULTS: All but one patient had chronic medically refractory epilepsy (median duration 8 years, range 0.5-52 years). Lesions were located in the temporal (13), frontal (five), and parietal (one) lobes. CCMs induced magnetic susceptibility artifacts during thermometry, but perilesional cortex was easily visualized. Fourteen of 17 patients (82%) with >12 months of follow-up achieved Engel class I outcomes, of which 10 (59%) were Engel class IA. Two patients who were not seizure-free from SLA alone became so following intracranial electrode-guided open resection. Delayed postsurgical imaging validated CCM involution (median 83% volume reduction) and ablation of surrounding cortex. Histopathologic examination of one previously ablated CCM following open surgery confirmed obliteration. SLA caused no detectable hemorrhages. Two symptomatic neurologic deficits (visual and motor) were predictable, and neither was permanently disabling. SIGNIFICANCE: In a consecutive retrospective series, MR thermography-guided SLA was an effective alternative to open surgery for epileptogenic CCM. The approach was free of hemorrhagic complications, and clinically significant neurologic deficits were predictable. SLA presents no barrier to subsequent open surgery when needed. Wiley Periodicals, Inc.
Authors: F Bartolomei; J Régis; Y Kida; T Kobayashi; V Vladyka; R Liscàk; D M Forster; A Kemeny; O Shrötner; G Pendl Journal: Stereotact Funct Neurosurg Date: 1999 Impact factor: 1.875
Authors: N F Moran; D R Fish; N Kitchen; S Shorvon; B E Kendall; J M Stevens Journal: J Neurol Neurosurg Psychiatry Date: 1999-05 Impact factor: 10.154
Authors: Roger J McNichols; Ashok Gowda; Marko Kangasniemi; James A Bankson; Roger E Price; John D Hazle Journal: Lasers Surg Med Date: 2004 Impact factor: 4.025
Authors: Christian R Baumann; Bernhard Schuknecht; Giorgio Lo Russo; Massimo Cossu; Alberto Citterio; Frederick Andermann; Adrian M Siegel Journal: Epilepsia Date: 2006-03 Impact factor: 5.864
Authors: Kunal Gupta; Brian Cabaniss; Ammar Kheder; Satyanarayana Gedela; Paul Koch; Kelsey C Hewitt; Abdulrahman Alwaki; Christopher Rich; Supriya Ramesha; Ranliang Hu; Daniel L Drane; Robert E Gross; Jon T Willie Journal: Epilepsia Date: 2020-08-10 Impact factor: 5.864
Authors: Laurèl Rauschenbach; Pauline Bartsch; Alejandro N Santos; Annika Lenkeit; Marvin Darkwah Oppong; Karsten H Wrede; Ramazan Jabbarli; Witold X Chmielewski; Börge Schmidt; Carlos M Quesada; Michael Forsting; Ulrich Sure; Philipp Dammann Journal: Brain Behav Date: 2022-04-25 Impact factor: 3.405
Authors: Alexander A Hedaya; Kelsey C Hewitt; Ranliang Hu; Charles M Epstein; Robert E Gross; Daniel L Drane; Jon T Willie Journal: Epilepsy Behav Date: 2022-03-23 Impact factor: 3.337
Authors: Christian Dorfer; Bertil Rydenhag; Gordon Baltuch; Vivek Buch; Jeffrey Blount; Robert Bollo; Jason Gerrard; Daniel Nilsson; Karl Roessler; James Rutka; Ashwini Sharan; Dennis Spencer; Arthur Cukiert Journal: Epilepsia Date: 2020-03-29 Impact factor: 6.740